Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Chinese Medical Journal ; (24): 3283-3291, 2015.
Article in English | WPRIM | ID: wpr-275518

ABSTRACT

<p><b>BACKGROUND</b>Plantar pressure serves as a key factor for predicting ulceration in the feet of diabetes patients. We designed this study to analyze plantar pressure changes and correlating risk factors in Chinese patients with type 2 diabetes.</p><p><b>METHODS</b>We recruited 65 patients with type 2 diabetes. They were invited to participate in the second wave 2 years later. The patients completed identical examinations at the baseline point and 2 years later. We obtained maximum force, maximum pressure, impulse, pressure-time integral, and loading rate values from 10 foot regions. We collected data on six history-based variables, six anthropometric variables, and four metabolic variables of the patients.</p><p><b>RESULTS</b>Over the course of the study, significant plantar pressure increases in some forefoot portions were identified (P < 0.05), especially in the second to forth metatarsal heads. Decreases in heel impulse and pressure-time integral levels were also found (P < 0.05). Plantar pressure parameters increased with body mass index (BMI) levels. Hemoglobin A1c (HbA1c) changes were positively correlated with maximum force (β = 0.364, P = 0.001) and maximum pressure (β = 0.366, P = 0.002) changes in the first metatarsal head. Cholesterol changes were positively correlated with impulse changes in the lateral portion of the heel (β = 0.179, P = 0.072) and pressure-time integral changes in the second metatarsal head (β = 0.236, P = 0.020). Ankle-brachial index (ABI) changes were positively correlated with maximum force changes in the first metatarsal head (β = 0.137, P = 0.048). Neuropathy symptom score (NSS) and common peroneal nerve sensory nerve conduction velocity (SCV) changes were positively correlated with some plantar pressure changes. In addition, plantar pressure changes had a correlation with the appearance of infections, blisters (β = 0.244, P = 0.014), and calluses over the course of the study.</p><p><b>CONCLUSIONS</b>We should pay attention to the BMI, HbA1c, cholesterol, ABI, SCV, and NSS changes in the process of preventing high plantar pressure and ulceration. Some associated precautions may be taken with the appearance of infections, blisters, and calluses.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Asian People , Diabetes Mellitus, Type 2 , Diabetic Foot , Diagnosis , Foot , Pressure , Prospective Studies , Risk Factors
2.
China Journal of Chinese Materia Medica ; (24): 264-266, 2004.
Article in Chinese | WPRIM | ID: wpr-256374

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the role and mechanism of Astragalus (AS) and saponins of Panax notoginseng (PNS) in treating type 2 diabetic macroangiopathy.</p><p><b>METHOD</b>94 patients with type 2 diabetic macroangiopathy were divided into two groups randomly: group treated with Simvastatin and group treated with AS and PNS, compared with 40 healthy control subjects. Serum level of MMP-9 and lipid in patients and healthy subjects were measured before and after treatment.</p><p><b>RESULT</b>The serum levels of MMP-9, TG, TC, LDL-C, VLDL-C in patients with type 2 diabetic macroangiopathy were improved, while the levels of HDL-C were decreased. Like Simvastatin AS and PNS had the function of reducing MMP-9 and accommodating lipid metabolism.</p><p><b>CONCLUSION</b>Besides accommodating lipid metabolism, AS and PNS can also reduce the level of serum MMP-9 soas to treat type 2 diabetic macroangiopathy.</p>


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Astragalus propinquus , Chemistry , Diabetes Mellitus, Type 2 , Blood , Drug Therapy , Diabetic Angiopathies , Blood , Drug Therapy , Drug Combinations , Drugs, Chinese Herbal , Pharmacology , Ginsenosides , Therapeutic Uses , Hypolipidemic Agents , Therapeutic Uses , Lipids , Blood , Matrix Metalloproteinase 9 , Blood , Panax , Chemistry , Phytotherapy , Plants, Medicinal , Chemistry , Simvastatin , Therapeutic Uses
SELECTION OF CITATIONS
SEARCH DETAIL